Deregulation of MCM2–7 can be potential biomarkers in meningioma tumor tissues[37].Consistent with the previous findings, our present work observed deregulations of MCM1–10 genes in LUAD cancer tissues which can be serve as potential diagnostic biomarkers. This evidence concerns the gene SRF and meningioma.